Drug intelligence / Profile preview

HIV-1 DNA vaccine + protein vaccine

Development stage
Unknown
Lead developer
FIT Biotech
Modality
DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Intradermal, Intramuscular, Subcutaneous, Intranasal, Transcutaneous
01

Overview

HIV-1 DNA vaccine + protein vaccine is a combination immunization approach that uses both DNA plasmids encoding HIV-1 envelope proteins and recombinant HIV-1 envelope proteins to elicit enhanced immune responses against HIV-1. This approach combines the advantages of DNA vaccination (strong T-cell responses) with protein vaccination (robust antibody responses). The DNA component typically consists of plasmids encoding HIV-1 envelope glycoproteins, while the protein component consists of recombinant HIV-1 envelope proteins such as gp120 or gp140. The combination can be administered either as a prime-boost regimen (DNA followed by protein) or as co-administration (DNA and protein given simultaneously). Enhanced delivery methods such as electroporation are often used to improve cellular transfection of the DNA component. This combination approach has been shown to elicit higher antibody responses than either DNA or protein alone, with broader cross-neutralizing activity, while maintaining strong cellular immune responses.

Other names
DNA prime-protein boostDNA&protein co-immunizationDNA and protein co-administration
02

Targets

Env (HIV-1 envelope glycoprotein)

Beyond the preview

Go deeper on HIV-1 DNA vaccine + protein vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 DNA vaccine + protein vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call